MAGNANI, ELIANA
 Distribuzione geografica
Continente #
NA - Nord America 567
EU - Europa 467
AS - Asia 157
AF - Africa 7
Totale 1.198
Nazione #
US - Stati Uniti d'America 565
RU - Federazione Russa 197
PL - Polonia 128
IE - Irlanda 53
CN - Cina 51
IT - Italia 39
HK - Hong Kong 28
SE - Svezia 28
SG - Singapore 26
JO - Giordania 19
SA - Arabia Saudita 15
IN - India 14
CI - Costa d'Avorio 7
GB - Regno Unito 7
DE - Germania 5
UA - Ucraina 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
IL - Israele 2
KR - Corea 2
FI - Finlandia 1
Totale 1.198
Città #
Warsaw 128
Santa Clara 106
Fairfield 67
Chandler 57
Dublin 53
Beijing 29
Seattle 26
Houston 25
Singapore 22
Ashburn 21
Cambridge 21
Lawrence 21
Woodbridge 21
Hong Kong 20
Altamura 19
Wilmington 19
Ann Arbor 16
Mumbai 13
Princeton 13
Riyadh 13
New York 12
Buffalo 10
Kent 9
Abidjan 7
Boston 7
Dearborn 7
Moscow 7
Shanghai 7
London 5
Medford 5
Florence 4
Norwalk 4
Genoa 3
San Diego 3
Barcelona 2
Bern 2
Bremen 2
Brussels 2
Buraidah 2
Faenza 2
Falls Church 2
Forlì 2
Hefei 2
Kiryat Ono 2
Seoul 2
Toronto 2
Verdellino 2
Bielefeld 1
Foggia 1
Fuzhou 1
Guangzhou 1
Hanover 1
Hebei 1
Hyderabad 1
Kunming 1
Milan 1
Nanjing 1
Phoenix 1
Pontassieve 1
Portland 1
Redwood City 1
Reggio Calabria 1
Wenzhou 1
Ürümqi 1
Totale 843
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 251
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 131
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 100
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 94
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 93
Association of celiac disease in patients with multiple sclerosis in Tuscany 91
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 90
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 88
Leptomeningeal enhancement analysis in diagnostic clinical setting 76
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 75
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 68
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 65
Totale 1.222
Categoria #
all - tutte 3.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 0 0 0 0 17 7 20 23 27 26 18 2
2020/202189 8 6 3 14 9 14 4 7 8 10 3 3
2021/202284 1 7 5 6 2 7 6 6 2 5 11 26
2022/2023255 20 47 19 6 20 44 34 14 43 1 4 3
2023/2024108 2 10 13 9 8 10 4 23 1 2 16 10
2024/2025393 28 71 50 106 138 0 0 0 0 0 0 0
Totale 1.222